Abstract
Drug use reemerged in China after the 1978 introduction of sweeping economic change initiated by the “Opening Up and Reform” policy, and the high-risk behavior of drug users was the major driver of China’s early HIV epidemic. To combat both the growing drug use and HIV epidemics, China’s National Methadone Maintenance Treatment (MMT) Program was piloted in 2004 and scaled up starting in 2006. By the end of 2015, the program encompassed 785 full-service clinics, 29 mobile vans, and 325 satellite sites nationwide that were providing MMT services to more than 170,000 regular clients who were former heroin injectors. China’s National MMT Program had become the largest opioid substitution therapy program in the world. This important harm reduction program has successfully reduced illicit drug use, HIV incidence, mortality, and criminal activity, as well as improved quality of life. However, there are still a wide range of challenges and gaps remaining, and further work to strengthen this program will be necessary for HIV to be eliminated in this important key population.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ausubel DP. The Dole-Nyswander treatment of heroin addiction. JAMA. 1966;195(11):949–50. https://doi.org/10.1001/jama.1966.03100110117032.
Brugal M, Domingo-Salvany A, Puig R, Barrio G, García de Olalla P, de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and AIDS in a cohort of heroin users in Spain. Addiction. 2005;100(7):981–9. https://doi.org/10.1111/j.1360-0443.2005.01089.x.
Cao XB, Wu ZY, Li L, Pang L, Rou K, Wang C, et al. Mortality among methadone maintenance clients in China: a six-year cohort study. PLoS One. 2013;8(12):e82476. https://doi.org/10.1371/journal.pone.0082476.
Cao X, Wu Z, Rou K, Li L, Lin C, Wang C, Luo W, et al. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study. Drug Alcohol Depend. 2014;145:87–93. https://doi.org/10.1016/j.drugalcdep.2014.09.776.
Chinese Center for Disease Control and Prevention. National sentinel surveillance report of HIV infection, 2004. Beijing: Chinese Center for Disease Control and Prevention; 2004.
Corsi KF, Booth RE. HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present. Curr Drug Abuse Rev. 2008;1(3):292–6. https://doi.org/10.2174/1874473710801030292.
Degenhardt L, Hall W, Warner-Smith M. Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sex Transm Infect. 2006;82(Suppl 3):iii56–63. https://doi.org/10.1136/sti.2005.019273.
Fang YX, Wang YB, Shi J, Liu ZM, Lu L. Recent trends in drug abuse in China. Acta Pharmacol Sin. 2006;27:140–4. https://doi.org/10.1111/j.1745-7254.2006.00270.x.
Fiellin DA, O’Connor PG, Chawarski M, Pakes JP, Pantalon MV, Schottenfeld RS. Methadone maintenance in primary care: a randomized controlled trial. JAMA. 2001;286(14):1724–31. https://doi.org/10.1001/jama.286.14.1724.
Hulse GK, English DR, Milne E, Holman CD. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94(2):221–9. https://doi.org/10.1046/j.1360-0443.1999.9422216.x.
Jia Z, Liu Z, Chu P, McGoogan JM, Cong M, Shi J, et al. Tracking the evolution of drug abuse in China, 2003–10: a retrospective, self-controlled study. Addiction. 2015;110(Suppl 1):4–10. https://doi.org/10.1111/add.12769.
Joe Laidler KA. The rise of club drugs in a heroin society: the case of Hong Kong. Subst Use Misuse. 2005;40(9–10):1257–78. https://doi.org/10.1081/JA-200066788.
Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a review of historical and clinical issues. Mt Sinai J Med. 2000;67(5–6):347–64.
Kerr T, Marsh D, Li K, Montaner J, Wood E. Factors associated with methadone maintenance therapy use among a cohort of poly-substance using injection drug users in Vancouver. Drug Alcohol Depend. 2005;80(3):329–35. https://doi.org/10.1016/j.drugalcdep.2005.05.002.
Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. Methadone maintenance treatment modalities in relation to incidence of HIV: results of the Amsterdam cohort study. AIDS. 1999;13(13):1711–6.
Li J, Ha TH, Zhang C, Liu H. The Chinese government’s response to drug use and HIV/AIDS: a review of policies and programs. Harm Reduct J. 2010;7:4. https://doi.org/10.1186/1477-7517-7-4.
Li L, Wu Z, Cao X, Zhang L. Provider-client interaction in methadone treatment clinics in China. J Drug Issues 2012;42(2). https://doi.org/10.1177/0022042612446593.
Li J, Wang C, McGoogan JM, Rou K, Bulterys M, Wu Z. Human resource development and capacity-building during China’s rapid scale-up of methadone maintenance treatment services. Bull World Health Organ. 2013;91(2):130–5. https://doi.org/10.2471/BLT.12.108951.
Lin C, Wu Z, Rou K, Pang L, Cao X, Shoptaw S, et al. Challenges in providing services in methadone maintenance therapy clinics in China: service providers’ perceptions. Int J Drug Policy. 2010;21(3):173–8. https://doi.org/10.1016/j.drugpo.2009.09.002.
Lin C, Detels R. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China. Drug Alcohol Depend. 2011;117(1):45–9. https://doi.org/10.1016/j.drugalcdep.2011.01.004.
Lin C, Li L, Cao X. Client acceptability for integrating antiretroviral therapy in methadone maintenance therapy clinics in Sichuan, China. Subst Use Misuse. 2017;52(1):119–26. https://doi.org/10.1080/10826084.2016.1222622.
Liu H, Grusky O, Zhu Y, Li X. Do drug users who frequently receive detoxification treatment change their risky drug use practices and sexual behavior? Drug Alcohol Depend. 2006;84(1):114–21. https://doi.org/10.1016/j.drugalcdep.2006.01.004.
Liu E, Liang T, Shen L, Zhong H, Wang B, Wu Z, et al. Correlates of methadone client retention: a prospective cohort study in Guizhou province, China. Int J Drug Policy. 2009;20(4):304–8. https://doi.org/10.1016/j.drugpo.2008.09.004.
Liu Y, Liang J, Zhao C, Zhou W. Looking for a solution for drug addiction in China: exploring the challenges and opportunities in the way of China’s new Drug Control Law. Int J Drug Policy. 2010;21(3):149–54. https://doi.org/10.1016/j.drugpo.2009.10.002.
Liu E, Rou K, McGoogan JM, Pang L, Cao X, Wang C, et al. Factors associated with mortality of HIV positive clients receiving methadone maintenance treatment in China. J Infect Dis. 2013;208(3):442–53. https://doi.org/10.1093/infdis/jit163.
Lu L, Wang X. Drug addiction in China. Ann N Y Acad Sci. 2008;1141:304–17. https://doi.org/10.1196/annals.1441.025.
Lu L, Fang Y, Wang X. Drug abuse in China: past, present and future. Cell Mol Neurobiol. 2008;28(4):479–90. https://doi.org/10.1007/s10571-007-9225-2.
Ma Y, Li Z, Zhang K. HIV was first discovered among injection drug users in China. Chin J Epidemiol. 1990;11:184–5.
Mao Y, Wu Z, Poundstone K, Wang C, Qin Q, Ma Y, et al. Development of a unified web-based national HIV/AIDS information system in China. Int J Epidemiol. 2010;39(Suppl 2):ii79–89. https://doi.org/10.1093/ije/dyq213.
McCowan C, Kidd B, Fahey T. Factors associated with mortality in Scottish patients receiving methadone in primary care: retrospective cohort study. BMJ. 2009;338:b2225. https://doi.org/10.1136/bmj.b2225.
McCoy CB, McCoy HV, Lai S, Yu Z, Wang X, Meng J. Reawakening the dragon: changing patterns of opiate use in Asia, with particular emphasis on China’s Yunnan province. Subst Use Misuse. 2001;36(1–2):49–69.
Meng J, Burris S. The role of the Chinese police in methadone maintenance therapy: a literature review. Int J Drug Policy. 2013;24(6):e25–34. https://doi.org/10.1016/j.drugpo.2013.03.010.
Ministry of Health, Ministry of Public Security, State Food and Drug Administration. Implementation protocol of the community-based methadone maintenance treatment program for opiate addicts in China. Beijing: Ministry of Health, Ministry of Public Security, and State Food and Drug Administration, People’s Republic of China; 2006.
Morgan O, Johnson H, Rooney C, Seagroatt V, Griffiths C. Changes to the daily pattern of methadone-related deaths in England and Wales, 1993–2003. J Public Health (Oxf). 2006;28(4):318–23. https://doi.org/10.1093/pubmed/fdl059.
National Health and Family Planning Commission. 2015 China AIDS response progress report. Beijing: National Health and Family Planning Commission. http://www.commuhealtibet.org/wp-content/uploads/2016/11/CHN_narrative_report_2015.pdf. Accessed 27 Sep 2018.
National Narcotic Control Commission. Annual report on drug control in China. Beijing: National Narcotics Control Commission, People’s Republic of China; 2005.
National Narcotics Control Commission. Annual report on drug control in China. Beijing: National Narcotics Control Commission, People’s Republic of China; 2013.
National Narcotics Control Commission. Annual report on drug control in China. Beijing: National Narcotics Control Commission, People’s Republic of China; 2015.
Pang L, Hao Y, Mi G, Wang C, Luo W, Rou K, et al. Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS. 2007;21(Suppl 8):S103–7. https://doi.org/10.1097/01.aids.0000304704.71917.64.
Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25(1):43–50. https://doi.org/10.1300/J069v25n01_07.
Shao Y, Chen Z, Wang B, Zeng Y, Zhao SD, Zhang ZR. Isolation of viruses from HIV infected individuals in Yunnan. Chin J Epidemiol. 1991;12:129.
Shi J, Zhao LY, Epstein DH, Zhang XL, Lu L. Long-term methadone maintenance reduces protracted symptoms of heroin abstinence and cue-induced craving in Chinese heroin abusers. Pharmacol Biochem Behav. 2007;87(1):141–5. https://doi.org/10.1016/j.pbb.2007.04.010.
Standing Committee of the National People’s Congress of China. Drug control law. Beijing: Standing Committee of the National People’s Congress of China, People’s Republic of China; 2008.
State Council. China’s action plan for reducing and preventing the spread of HIV/AIDS (2001–2005). Beijing: State Council, People’s Republic China; 2001.
State Council. Regulations on AIDS prevention and treatment. Beijing: State Council, People’s Republic of China; 2006a.
State Council. Action plan on HIV/AIDS prevention and containment (2006–2010). Beijing: State Council, People’s Republic of China; 2006b.
State Council AIDS Working Committee Office and the United Nations Theme Group on HIV/AIDS in China. A joint assessment of HIV/AIDS prevention, treatment and care in China. Beijing: State Council AIDS Working Committee Office and the United Nations Theme Group on HIV/AIDS in China; 2004.
Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA. 1999;281(11):1000–5. https://doi.org/10.1001/jama.281.11.1000.
Sullivan SG, Wu Z. Rapid scale up of harm reduction in China. Int J Drug Policy. 2007;18(2):118–28. https://doi.org/10.1016/j.drugpo.2006.11.014.
Sullivan SG, Wu Z, Cao X, Liu E, Detels R. Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users. J Subst Abus Treat. 2014;47(1):86–92. https://doi.org/10.1016/j.jsat.2013.12.004.
Sullivan SG, Wu Z, Rou K, Pang L, Luo W, Wang C, et al. Who uses methadone services in China? Monitoring the world’s largest methadone programme. Addiction. 2015;110(Suppl 1):29–39. https://doi.org/10.1111/add.12781.
Sun X, Wang N, Li D, Zheng X, Qu S, Wang L, et al. The development of HIV/AIDS surveillance in China. AIDS. 2007;21(Suppl 8):S33–8. https://doi.org/10.1097/01.aids.0000304694.54884.06.
Sun X, Lu F, Wu Z, Poundstone K, Zeng G, Xu P, et al. Evolution of information-driven HIV/AIDS policies in China. Int J Epidemiol. 2010;39(Suppl 2):ii4–13. https://doi.org/10.1093/ije/dyq217.
Sun HM, Li XY, Chow EP, Li T, Xian Y, Lu YH, et al. Methadone maintenance treatment programme reduces criminal activity and improves social well-being of drug users in China: a systematic review and meta-analysis. BMJ Open. 2015;5(1):e005997. https://doi.org/10.1136/bmjopen-2014-005997.
United Nations Office on Drugs and Crime. World drug report 2012. Vienna: United Nations Office on Drugs and Crime; 2012.
Urbina A, Jones K. Crystal methamphetamine, its analogues, and HIV infection: medical and psychiatric aspects of a new epidemic. Clin Infect Dis. 2004;38(6):890–4. https://doi.org/10.1086/381975.
Volkow ND, Wang GJ, Fowler JS, Telang F, Jayne M, Wong C. Stimulant-induced enhanced sexual desire as a potential contributing factor in HIV transmission. Am J Psychiatry. 2007;164(1):157–60. https://doi.org/10.1176/ajp.2007.164.1.157.
Wang BX, Zhang L, Wang YJ, Yan JW, Wan YN, Peng WJ, et al. Epidemiology of syphilis infection among drug users at methadone maintenance treatment clinics in China: systemic review and meta-analysis. Int J STD AIDS. 2014;25(8):550–8. https://doi.org/10.1177/0956462413515444.
Wang L, Guo W, Li D, Ding Z, McGoogan JM, Wang N. HIV epidemic among drug users in China: 1995–2011. Addiction. 2015;110(Suppl 1):20–8. https://doi.org/10.1111/add.12779.
Wang C, Shi CX, Rou K, Zhao Y, Cao X, Luo W, et al. Baseline HCV antibody prevalence and risk factors among drug users in China’s National Methadone Maintenance Treatment Program. PLoS One. 2016;11(2):e0147922. https://doi.org/10.1371/journal.pone.0147922.
Ward J, Hall W, Mattick RP. Role of maintenance treatment in opioid dependence. Lancet. 1999;353(9148):221–6. https://doi.org/10.1016/S0140-6736(98)05356-2.
World Health Organization China Office. Reducing harm, preventing HIV, saving lives: China’s vast methadone maintenance treatment program marks successes even as it addresses key challenges ahead. Beijing: World Health Organization China Office; 2014. http://www.wpro.who.int/china/mediacentre/releases/2014/2014112702/en/. Accessed 27 Sep 2018.
World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention. Beijing: World Health Organization, United Nations Office on Drugs and Crime, Joint United Nations Programme on HIV/AIDS, 2004. http://www.who.int/hiv/pub/idu/position_paper_substitution_opioid/en/. Accessed 19 Sept 2018.
Wu Z, Pisani E. Fulfilling a promise: universal care. In: Wu Z, editor. HIV/AIDS in China—beyond the numbers. Singapore: People’s Medical Publishing House; 2017. p. 78–99.
Wu Z, Sullivan SG, Wang Y, Rotheram-Borus MJ, Detels R. Evolution of China’s response to HIV/AIDS. Lancet. 2007;369(9562):679–90. https://doi.org/10.1016/S0140-6736(07)60315-8.
Yin W, Hao Y, Sun X, Gong X, Li F, Li J. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol. 2010;39(Suppl 2):ii29–37. https://doi.org/10.1093/ije/dyq210.
Yin W, Pang L, Cao X, McGoogan JM, Liu M, Zhang C, et al. Factors associated with depression and anxiety among patients attending community-based methadone maintenance treatment in China. Addiction. 2015;110(Suppl 1):51–60. https://doi.org/10.1111/add.12780.
Zhang H. An analysis of the group characteristics of new-type drugs abuse in Dehong prefecture. J Yunnan Police Officer Acad. 2006;4:16–8.
Zhang L, Chow EP, Zhuang X, Liang Y, Wang Y, Tang C, et al. Methadone maintenance treatment participant retention and behavioral effectiveness in China: a systematic review and meta-analysis. PLoS One. 2013;8:e68906. https://doi.org/10.1371/journal.pone.0068906.
Zhao Y, Shi CX, McGoogan JM, Rou K, Zhang F, Wu Z. Methadone maintenance treatment and mortality in HIV-positive people who inject opioids in China. Bull World Health Organ. 2013;91(2):93–101. https://doi.org/10.2471/BLT.12.108944.
Zheng X, Tian C, Choi KH, Zhang J, Cheng H, Yang X, et al. Injecting drug use and HIV infection in southwest China. AIDS. 1994;8:1141–7.
Zhou Y, Zhuang G. Retention in methadone maintenance treatment in mainland China, 2004–2012: a literature review. Addict Behav. 2014;39(1):22–9. https://doi.org/10.1016/j.addbeh.2013.09.001.
Zhou Y, Wu Z, McGoogan JM, Luo W, Zhang B, Wu L, et al. Mortality and associated factors among methadone maintenance treatment clients in Yunnan, China: an eleven-year cohort study. J Addict Med. 2019 (under review).
Zhuang X, Liang Y, Chow EP, Wang Y, Wilson DP, Zhang L. HIV and HCV prevalence among entrants to methadone maintenance treatment clinics in China: a systematic review and meta-analysis. BMC Infect Dis. 2012;12:130. https://doi.org/10.1186/1471-2334-12-130.
Zou X, Ling L, Zhang L. Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. BMJ Open. 2015;5(8):e008162. https://doi.org/10.1136/bmjopen-2015-008162.
Acknowledgments
The authors would like to thank Willa Dong and Jennifer M. McGoogan for providing editorial assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Cao, X., Lin, C., Wang, C., Wu, Z. (2020). The National Methadone Maintenance Treatment Program. In: Wu, Z., Wang, Y., Detels, R., Bulterys, M., McGoogan, J. (eds) HIV/AIDS in China. Springer, Singapore. https://doi.org/10.1007/978-981-13-8518-6_9
Download citation
DOI: https://doi.org/10.1007/978-981-13-8518-6_9
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-8517-9
Online ISBN: 978-981-13-8518-6
eBook Packages: MedicineMedicine (R0)